Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Yang Feng 888 Capital Limited | ICG Intchains Group Ltd | 13G | 13.8% | Dec 31, 2023 | 2y |
| WPGG 14 Investment Ltd. IV | DCBO Docebo Inc. | 13G/A | 9.91% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | JUN Juniper II Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| NOMURA HOLDINGS INC | CTLT CATALENT, INC. | 13G | 6.4% | Dec 31, 2023 | 2y |
| MSD Partners, L.P. | XPOF Xponential Fitness, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | BRLS Borealis Foods Inc. | 13G/A | 9.47% | Dec 31, 2023 | 2y |
| D. E. Shaw & Co., L.P. | AMAM Ambrx Biopharma, Inc. Common Stock | 13G/A | 6.7% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | KRNL Kernel Group Holdings, Inc. Class A Ordinary Shares | 13G/A | 3.12% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | ETRN Equitrans Midstream Corporation Common Stock | 13G/A | 1.5% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | AUPH Aurinia Pharmaceuticals Inc. | 13G | 6.64% | Dec 31, 2023 | 2y |
| Samarra Company Lmited | VNET VNET Group, Inc. | 13G/A | 8.4% | Dec 31, 2023 | 2y |
| Exor N.V. | HMY Harmony Gold Mining Co Ltd | 13G/A | 4.8% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | MIR Mirion Technologies, Inc. | 13G | 9.1% | Dec 31, 2023 | 2y |
| Paradigm Biocapital Advisors LP | ACLX Arcellx, Inc. | 13G/A | 7% | Dec 31, 2023 | 2y |
| Long Focus Capital Management, LLC | QMCO Quantum Corp | 13G/A | 9.6% | Dec 31, 2023 | 2y |
| (VOLUNTARY) Thad Beshears | TRLV Trulieve Cannabis Corp. | 13G/A | 3.76% | Dec 31, 2023 | 2y |
| D. E. Shaw & Co., L.P. | NIR Near Intelligence, Inc. Common Stock | 13G/A | 0.2% | Dec 31, 2023 | 2y |
| D. E. Shaw & Co., L.P. | TRTL TortoiseEcofin Acquisition Corp. III | 13G/A | 4.9% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | APLT Applied Therapeutics, Inc. Common Stock | 13G/A | 5.9% | Dec 31, 2023 | 2y |
| CANADA PENSION PLAN INVESTMENT BOARD | EQH Equitable Holdings, Inc. | 13G | 5.4% | Dec 31, 2023 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | PCVX Vaxcyte, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | RLMD Relmada Therapeutics, Inc. | 13G/A | 6.79% | Dec 31, 2023 | 2y |
| Timothy Vanderhook | DSP Viant Technology Inc. | 13G | 34.2% | Dec 31, 2023 | 2y |
| Rock Springs Capital Management LP | TPST Tempest Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Fundsmith LLP | SABR Sabre Corp | 13G/A | 5.9% | Dec 31, 2023 | 2y |
| SIT INVESTMENT ASSOCIATES INC | VTN Invesco Trust for Investment Grade New York Municipals | 13G | 6.41% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | BLPH Bellerophon Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | ESTA Establishment Labs Holdings Inc. | 13G/A | 9.7% | Dec 31, 2023 | 2y |
| BRAIDWELL LP | CRNX Crinetics Pharmaceuticals, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Roystone Management Holdings LLC | BTMD biote Corp. | 13G/A | 9% | Dec 31, 2023 | 2y |
| Paradigm Biocapital Advisors LP | VOR Vor Biopharma Inc. | 13G/A | 9.5% | Dec 31, 2023 | 2y |
| BRAIDWELL LP | DCPH Deciphera Pharmaceuticals, Inc. Common Stock | 13G/A | 2.92% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | MGEE Mge Energy Inc | 13G | 5.7% | Dec 31, 2023 | 2y |
| K2 HealthVentures Equity Trust LLC | CRBP Corbus Pharmaceuticals Holdings, Inc. | 13G/A | 7.5% | Dec 31, 2023 | 2y |
| Alger Associates, Inc. 13-3017981 | ALAI Alger ETF Trust | 13G/A | 14.9% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | RCAT Red Cat Holdings, Inc. | 13G | 6.7% | Dec 31, 2023 | 2y |
| BRAIDWELL LP | DBVT DBV Technologies S.A. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | VSEC Vse Corp | 13G | 9.7% | Dec 31, 2023 | 2y |
| SAMLYN CAPITAL, LLC | MRUS Merus N.V. Common Shares | 13G | 5.9% | Dec 31, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | EOLS Evolus, Inc. | 13G/A | 5.4% | Dec 31, 2023 | 2y |
| Boundary Creek Advisors LP | MERC Mercer International Inc. | 13G | 8.5% | Dec 31, 2023 | 2y |
| EdgePoint Investment Group Inc. | PSMT Pricesmart Inc | 13G/A | 8.9% | Dec 31, 2023 | 2y |
| Oaktree Capital Holdings, LLC | BRY Berry Corporation (bry) Common Stock | 13G/A | 4.89% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | NGNE Neurogene Inc. | 13G/A | 8.1% | Dec 31, 2023 | 2y |
| Oates-Fairrington Kathryn Ruth | FSBC Five Star Bancorp | 13G/A | 6.7% | Dec 31, 2023 | 2y |
| Cerberus Capital Management, L.P. | ACI Albertsons Companies, Inc. | 13G/A | 26.4% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | USPH U S Physical Therapy Inc | 13G | 5.1% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | TCOA Zalatoris Acquisition Corp. | 13G/A | 13.8% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | SLGL Sol-Gel Technologies Ltd. | 13G | 7.68% | Dec 31, 2023 | 2y |
| ArrowMark Colorado Holdings LLC | PMVP PMV Pharmaceuticals, Inc. | 13G | 5.31% | Dec 31, 2023 | 2y |